Novacyt (ALNOV.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 19,630 | 11,579 | 21,040 | 95,780 | 277,204 |
| Cost of Goods | -12,444 | 7,849 | 15,294 | 66,102 | 65,704 |
| Gross Profit | 32,074 | 3,730 | 5,746 | 29,678 | 211,500 |
| Operating Expenses | 48,734 | 21,892 | 21,421 | 30,308 | 36,577 |
| Operating Income | -16,660 | -18,162 | -15,675 | -630 | 174,923 |
| Interest Expense | 5,121 | 682 | 76 | 178 | 1,601 |
| Other Income | -17,649 | -9,724 | -4,302 | -9,021 | -8,151 |
| Pre-tax Income | -39,430 | -28,568 | -20,053 | -9,829 | 165,171 |
| Income Tax | -732 | -768 | 2,148 | -101 | 32,748 |
| Net Income Continuous | -38,698 | -27,800 | -22,201 | -9,728 | 132,423 |
| Net Income Discontinuous | -3,060 | -492 | -3,529 | N/A | N/A |
| Net Income | $-41,758 | $-28,292 | $-25,730 | $-9,728 | $132,423 |
| EPS Basic Total Ops | -0.59 | -0.40 | -0.36 | -0.14 | 1.94 |
| EPS Basic Continuous Ops | -0.55 | -0.39 | -0.31 | -0.14 | 1.94 |
| EPS Basic Discontinuous Ops | -0.04 | -0.01 | -0.05 | N/A | 0.00 |
| EPS Diluted Total Ops | -0.59 | -0.40 | -0.36 | -0.14 | 1.94 |
| EPS Diluted Continuous Ops | -0.55 | -0.39 | -0.31 | -0.14 | 1.94 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.01 | -0.05 | N/A | 0.00 |
| EBITDA(a) | $-34,309 | $-18,243 | $-12,059 | $-1,769 | $174,968 |